中科院纳米生物效应与安全性重点实验室
纳米技术论坛 (NS Forum No. 266)
第266期学术报告会通知 

演讲人:Lajos P Balogh, Ph.D.  （中国科学院外国专家特聘研究员）
            AA Nanomedicine and Nanotechnology, North Andover, Massachusetts 01845, USA
            Executive Editor, Manuscript Clinic
题   目: Nanomedicine Today: Achievements and Challenges
时   间: 2016年4月7日 (星期四), 上午10:00
地   点: 国家纳米科学中心，南楼二层会议室
主持人: 赵宇亮 研究员 

报告摘要: Nanomedicine and nanobiotechnology are rapidly emerging areas creating novel medically useful materials, substances, and procedures. Nanobiotechnology concentrates on new materials and medical technologies, while Nanomedicine focuses on the diagnosis, treatment, monitoring of patients as well as the prediction and prevention of diseases. Nanobiotechnology is developing better solutions to existing problems and Nanomedicine commercializes and applies these materials, devices and procedures. Together they have the potential to forever change how patients are diagnosed and treated in the next decade. However, all this nanobio-revolution is happening simultaneously with radical transformations in medical science and in the pharmaceutical industry. Apart from the great promises, there are many challenges for these paradigm-changing fields, especially in the area of communication and commercialization. In order not to produce only revolutionary discoveries, but affordable and economically competitive drugs, devices and clinical applications nanomedicine must be fueled by successful business. In this talk, the latest developments in nanomedicine and nanopharmaceuticals will be summarized from the point of view of commercialization, including popular topics, such as “personalized” medicine, “theranostics”, and “precision medicine”. Emerging research and market trends along with the introduction of a few real breakthroughs will also be illustrated.